
|Articles|June 10, 2012
VIDEO: Roman Hovorka, PhD, Talks About the Cost and Coverage Issues Associated with Continuous Glucose Monitoring
Roman Hovorka, PhD, talks about the prohibitive costs in continuous glucose monitoring. He states that if these costs can be reduced there will be wider acceptance and therefore a benefit to diabetes care.
Advertisement
Roman Hovorka, PhD, talks about the prohibitive costs in continuous glucose monitoring. He states that if these costs can be reduced there will be wider acceptance and therefore a benefit to diabetes care.
According to Hovorka, there are more issues in the United Kingdom compared to the United States at this time, although the costs of of continuous glucose monitoring prohibit widespread use in both countries.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Survodutide Phase 3 Data Signal Metabolic Gains Beyond Weight Loss
2
GLP-1 Drugs Tackle Both Skin Inflammation and Metabolism in Psoriasis
3
Oral Orforglipron Added to Basal Insulin Cuts HbA1c in Type 2 Diabetes
4
Childhood Influenza Vaccine Rates Decreased From 2017 to 2023
5




